Significant Shareholders

As at 7 October 2025, shareholders holding more than 3% of the share capital of Tissue Regenix Group Plc are:

Name of Shareholder Number of Shares % of Voting Rights
Harwood Capital (London) 15,790,000 22.12
Lombard Odier 7,939,294 11.12
Mr Richard Griffiths (UK) 7,926,190 11.09
Lexham Special Opportunities 4,140,025 5.80
IP Group (London) 2,390,403 3.35

 

Board of Directors

Name of Shareholder Number of Shares % of Voting Rights
Brian Phillips, Non-Executive Director  160,000 0.23
Daniel Lee, Chief Executive Officer 282,512 0.40
Shervanthi Homer-Vanniainkam, Non-Executive Director  16,382 0.02

 

Shares not in public hands as at 7 October 2025 - 33,259,657 - 46.59%

Shares in issue as at 7 October 2025 - 71,395,635 ordinary shares of 0.1p each

The securities of Tissue Regenix Group plc are traded on the AIM market operated by the London Stock Exchange plc. Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.

Key Advisors

You may also be interested in